FDA Inspection
Atlas Pharmaceuticals, LLCAtlas Pharmaceuticals, LLC – FDA Inspection, May 21, 2021
Record Details
This FDA Inspection record concerns Atlas Pharmaceuticals, LLC, with an inspection on May 21, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Atlas Pharmaceuticals, LLC
- Inspection Date
- May 21, 2021
- Product Type
- Drugs
View Company Profile
ID · f1baec26-643f-4965-adbb-068f69fdc15e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1142452
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)(3)Acceptance of drug products
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Atlas Pharmaceuticals, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 21, 2011 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Atlas Pharmaceuticals, LLC
- FDA Inspection 1026743 - 2017-09-26
- FDA Inspection 881606 - 2014-05-30
- FDA Inspection 759718 - 2011-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.